NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/10/2023
Back to search
Official data from USPTO
TRIALMAGNET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRIALMAGNET
ST13
US500000090689781Class
9, 35, 42
Filing
90689781
Registration
7190229
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/10/2023
Trademark type
Word
Nice classes
9, 35, 42
Filing date
05/04/2021
Registration date
10/10/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2023
Last transaction
10/10/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/21/2020
First use in commerce
04/14/2022
Drawing code
4
Owner type
03
Owner location
Herndon, VA, US
Examiner
NADELMAN, ANDREA KOYNER
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Jeeva Informatics Solutions, Inc.
Representatives
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Technical classification
Nice Classes
Class 9Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable software for the processing and analysis of data using artificial intelligence and natural language processing; downloadable software for planningmanagement and operational management in the field of clinical trials and long-term health management; downloadable software featuring machine learning technology for planningmanagementoperational managementstudy design optimization in the field of clinical trials and long-term health management; downloadable software for estimating the probability of clinical trial success; downloadable software featuring machine learning technology for capturingcollectingmanaginganalyzingreporting data from clinical trials and drug discovery for use in database management and processing data; downloadable software for real-time and long-term patient monitoring and safety review in the field of clinical trials
Class 35
Business consulting and management in the field of clinical trialsproviding information management services; business consulting and management in the field of clinical trials; business consulting and management in the field of regulatory submission managementclinical trial data integrity and immutability; database management in the field of clinical trials; updating and maintenance of data in computer databases in the field of clinical trials; recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; providing independent review of clinical trials for business purposes; regulatory submission managementassisting others in preparing and filing applications for approval of new drugs and medical devices with governmental regulatory bodies
Class 42
Software as a service (SAAS) services featuring software for the processing and analysis of data using artificial intelligence and natural language processing; Software as a service (SAAS) services featuring software for planningmanagement and operational management in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software featuring machine learning technology for planningmanagementoperational managementstudy design optimization in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software for estimating the probability of clinical trial success; Software as a service (SAAS) services featuring software featuring machine learning technology for capturingcollectingmanaginganalyzingreporting data from clinical trials and drug discovery for use in database management and processing data; scientific consulting services in the field of conducting clinical trials for others; information technology consulting services relating to the collectionreviewanalysis and reporting of clinical trialdrug developmentdrug discovery information; providing medical and scientific research information in the field of clinical trials; providing online searchable databases featuring medical and scientific research clinical trial information whereby users can input and collect data and information for research purposes; pharmaceutical research and development information services in the field of health care and clinical trials; Software as a service (SAAS) services featuring software for real-time and long-term patient monitoring and safety review in the field of clinical trials; Software as a service (SAAS) services featuring software for the processing and analysis of data for use in the discovery of disease biomarkers for diagnostic and therapeutic purposes; structural and functional analysis of genomes; database development servicesproviding configuration and customization of computer databases in the field of medical information related to clinical trials and late phase research; database development servicesproviding configuration and customization of computer databases in the field of medical information related healthcare and long-term health management; medical researchcompiling and analyzing genomics data for use in the discovery of disease biomarkers which are used for diagnostic and therapeutic purposes; conducting clinical trials for others; conducting early evaluations of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical and scientific research related to designingorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; medical researchcollectionorganizationanalysisreporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/10/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/29/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/29/2023
ALIE
ASSIGNED TO LIE
08/29/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/17/2022
GNRT
NON-FINAL ACTION E-MAILED
10/17/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/17/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/03/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/03/2022
IUAF
USE AMENDMENT FILED
09/21/2022
EISU
TEAS STATEMENT OF USE RECEIVED
09/21/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/12/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/15/2022
PUBO
PUBLISHED FOR OPPOSITION
02/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2022
GNRT
NON-FINAL ACTION E-MAILED
01/06/2022
CNRT
NON-FINAL ACTION WRITTEN
01/06/2022
DOCK
ASSIGNED TO EXAMINER
01/05/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2021
NWAP
NEW APPLICATION ENTERED
05/07/2021
Continuous trademark protection
Get notified about every new filing that threatens TRIALMAGNET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.